Kymera Therapeutics Inc

NASDAQ:KYMR   3:59:50 PM EDT
54.08
+0.40 (+0.74%)
Earnings Announcements

Kymera Therapeutics Announces Third Quarter 2021 Financial Results And Provides A Business Update

Published: 11/10/2021 12:12 GMT
Kymera Therapeutics Inc (KYMR) - Kymera Therapeutics Announces Third Quarter 2021 Financial Results and Provides a Business Update.
Kymera Therapeutics Inc - Net Loss Was $28.6 Million for Q3 of 2021.
Revenue is expected to be $21.46 Million
Adjusted EPS is expected to be -$0.43

Next Quarter Revenue Guidance is expected to be $21.4 Million
Next Quarter EPS Guidance is expected to be -$0.54

More details on our Analysts Page.